Home > News > Analysis: Sanofi's Taxotere keeps top spot
March 27th, 2007
Analysis: Sanofi's Taxotere keeps top spot
Abstract:
A nanoparticle formulation of Abraxis/AstraZeneca's Abraxane may also help drive market growth. A phase 2 trial comparing Abraxane to Taxotere in the metastatic breast cancer setting is slated to begin this year. If Abraxane has a strong showing in this trial, it could help propel growth of the market even more, the report forecasts.
Source:
upi.com
Bookmark:
Nanomedicine
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
MU Researchers Develop Radioactive Nanoparticles that Target Cancer Cells: This is an early step toward developing therapies for metastasized cancers, MU scientist says May 21st, 2013
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals
IDTechEx launches online Market Intelligence Portal May 23rd, 2013
Researchers Stitch Defects into the World’s Thinnest Semiconductor May 22nd, 2013
Whirlpools on the Nanoscale Could Multiply Magnetic Memory: At the Advanced Light Source, Berkeley Lab scientists join an international team to control spin orientation in magnetic nanodisks May 22nd, 2013
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Human Interest/Art
Oh, Christmas tree, oh Christmas tree: A nano end for Christmas tree needles January 2nd, 2013
INIC Inks MoU to Apply Nanotechnology in Iran's Carpet Industry December 18th, 2012
IBN Welcomes Its First 9-Year-Old ‘Scientist’: IBN and Make-A-Wish Foundation Singapore Make Kidney Patient’s Dream Come True December 10th, 2012
The music of the silks: Researchers synthesize a new kind of silk fiber — and find that music can help fine-tune the material’s properties November 28th, 2012